GlassScriptPhysician profile
Gregory J Miller
NPI 1225089790
$1,126.64
in general payments reported to CMS, 2019-2025
18 companies · $338 in 2025
The $338 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.79 · 2023: $16.75 · 2024: $707 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,060.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $240.53 | 2024-2025 | Keytruda, Lynparza, Welireg |
| Astrazeneca Pharmaceuticals LP | $182.26 | 2024-2025 | Enhertu, Calquence, Tagrisso |
| Janssen Biotech, INC. | $103.65 | 2024-2025 | Rybrevant, Erleada, Darzalex |
| Myriad Genetic Laboratories, INC. | $102.75 | 2024-2025 | Precisetumor, Myrisk |
| Medtronic USA, INC. | $65.79 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.01 | 2024-2025 | Ninlaro, Iclusig, Fruzaqla |
| Bayer Healthcare Pharmaceuticals INC. | $59.29 | 2025 | |
| Daiichi Sankyo INC. | $52.56 | 2024 | Enhertu |
| Abbvie INC. | $44.95 | 2024 | |
| Genentech USA, INC. | $29.17 | 2024 | Phesgo, Polivy |
| Karyopharm Therapeutics INC. | $28.35 | 2025 | Xpovio |
| Progenics Pharmaceuticals, INC. | $25.91 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $24.84 | 2024 | Libtayo |
| Kyowa Kirin, INC. | $24.53 | 2024 | Poteligeo |
| Novartis Pharmaceuticals Corporation | $21.94 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $20.04 | 2024 | |
| Geron Corporation | $19.32 | 2025 | Rytelo |
| Siemens Medical Solutions USA, INC. | $16.75 | 2023 | Aria Radiation Therapy Management Software |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.